Pre-malignant disease in the prostate

Alastair D. Lamb, Anne Y. Warren, David E. Neal

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Carcinoma of the prostate (CaP) is the most common non-cutaneous cancer in men and the second most common cause of cancer related death. Mortality remains high despite improvements in diagnosis in the developed world. A better understanding of the mechanisms involved in the development of prostate cancer should allow targeted diagnosis, prevention and treatment, and may improve mortality. In this chapter, we outline the two principal pre-malignant histological types, prostate intraepithelial neoplasia (PIN) and atypical small acinar proliferation (ASAP) and the likelihood of progression to CaP if these diagnoses are made. We then assess current understanding of factors contributing to the initiation of pre-malignant disease and progression to CaP as they relate to stem cells, inflammation, diet and specific genetic mutations or aberrant pathways. Finally, we discuss the translational potential of these factors in early detection and prevention of CaP.

Original languageEnglish
Title of host publicationPre-Invasive Disease
Subtitle of host publicationPathogenesis and Clinical Management
PublisherSpringer New York
Pages467-491
Number of pages25
ISBN (Print)9781441966933
DOIs
StatePublished - 2011
Externally publishedYes

Fingerprint

Dive into the research topics of 'Pre-malignant disease in the prostate'. Together they form a unique fingerprint.

Cite this